Prosecution Insights
Last updated: October 25, 2026
Application No. 18/141,427

CONTINGENT CARDIO-PROTECTION FOR EPILEPSY PATIENTS

Final Rejection §102
Filed
Apr 30, 2023
Priority
Jan 25, 2008 — CIP of 8565867 +9 more
Examiner
HULBERT, AMANDA K
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Flint Hills Scientific LLC
OA Round
7 (Final)
85%
Grant Probability
Favorable
8-9
OA Rounds
0m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 85% — above average
85%
Career Allowance Rate
659 granted / 778 resolved
+14.7% vs TC avg
Minimal +4% lift
Without
With
+4.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
25 currently pending
Career history
813
Total Applications
across all art units

Statute-Specific Performance

§101
4.0%
-36.0% vs TC avg
§103
41.9%
+1.9% vs TC avg
§102
25.0%
-15.0% vs TC avg
§112
22.9%
-17.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 778 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Response to Amendment Applicant’s amendment dated September 24,2026 is acknowledged. Currently claims 1-10, 12-13, and 15-17 are pending in this application, with claims 1-9 withdrawn from consideration. Response to Arguments Applicant’s arguments regarding the rejections under 35 U.S.C. 102 have been considered but are not persuasive. Applicant argues that Libbus does not disclose a logic unit configured via one or more processors to compare a monitored value with is determined based on one or more data points relating the heart rate to one or more threshold values. Examiner disagrees. Libbus discloses a logic unit (e.g. stimulation control circuit 336 as previously cited in Figure 3 which is further broken down in Figure 4, including a stimulation parameter adjustment circuit 444 which adjust parameters based on a heart rate threshold as disclosed in [0038]). The heart rate threshold values used in Libbus can be considered “a monitored value which is determined based on one or more data points relating the heart rate to one or more threshold values” and thus fulfills the limitations of the claims. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States. Claims 10, 12, 13, 15-17 are rejected under pre-AIA 35 U.S.C. 102(b) as being anticipated by Libbus (US 2006/0253161). Regarding claim 10, Libbus teaches a system for treating a medical condition in a patient, comprising: a sensor for sensing at least one body data stream (e.g. sensors 990 as shown in Figure 9); at least one electrode (e.g. electrodes attached to neural leads 903 as shown in Figure 9); a programmable electrical signal generator (e.g. implantable medical device 910); a heart rate unit capable of determining a heart rate of the patient based on the at least one body data stream (e.g. heart rate sensing circuit 862); and a logic unit configured via one or more processors to compare a monitored value which is determined based on one or more data points relating to the heart rate to one or more threshold values, the logic unit further configured to determine a first triggering event based on the comparison (e.g. stimulation control circuit 336); wherein the one or more processors are configured to initiate one or more actions to change the heart rate of the patient based on the determination of the first triggering event; the one or more processors are configured to via the at least one electrode increase a sympathetic tone or to decrease a parasympathetic tone to increase the heart rate of the patient based on the first triggering event via the programmable electrical signal generator (e.g. adjustment of sympathetic stimulation controller 338 based upon the patient’s heart rate as disclosed in [0038]).. Regarding claim 12, Libbus additionally discloses wherein the logic unit is further configured to determine a second triggering event based on the comparison (e.g. the stimulation control unit as disclosed in 336 and 436 work in an iterative fashion, and will thus necessarily receive a second triggering event). Regarding claim 13, Libbus additionally discloses wherein the one or more processors are configured to decrease a sympathetic tone to decrease the heart rate of the patient based on the second triggering event via the programmable electrical signal generator (e.g. decreasing sympathetic when a heart rate exceeds a predetermined threshold as disclosed in [0038]). Regarding claim 15, Libbus additionally discloses wherein the one or more processors are configured to decrease the parasympathetic tone to increase the heart rate of the patient based on the third triggering event via the programmable electrical signal generator (e.g. decreasing the parasympathetic tone to increase the heart rate when the heart rate falls below a predetermined threshold as taught in [0038]). Regarding claim 16, Libbus additionally discloses wherein the logic unit is further configured to determine an Nth triggering event based on the comparison (e.g. the stimulation control unit as disclosed in 336 and 436 work in an iterative fashion, and will thus necessarily receive a Nth triggering event). Regarding claim 17, Libbus additionally discloses wherein the one or more processors are configured to increase the sympathetic tone to increase the heart rate of the patient based on the Nth triggering event via the programmable electrical signal generator (e.g. increase of sympathetic tone to increase heart rate as disclosed in [0038], wherein the stimulation control unit as disclosed in 336 and 436 work in an iterative fashion, and will thus necessarily receive a Nth triggering event). Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Amanda K Hulbert whose telephone number is (571)270-1912. The examiner can normally be reached Monday - Friday 9:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Unsu Jung can be reached at 571-272-8506. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Amanda K Hulbert/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Show 10 earlier events
Oct 15, 2025
Response after Non-Final Action
Jan 09, 2026
Request for Continued Examination
Jan 30, 2026
Response after Non-Final Action
Feb 09, 2026
Non-Final Rejection mailed — §102
May 11, 2026
Response Filed
Jun 26, 2026
Non-Final Rejection mailed — §102
Sep 24, 2026
Response Filed
Oct 09, 2026
Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12766313
EXTENSION OF A PREVIOUSLY IMPLANTED LEAD OR ELECTRODE
2y 8m to grant Granted Oct 20, 2026
Patent 12766312
Defibrillation System Having Deformable Paddle Head
3y 3m to grant Granted Oct 20, 2026
Patent 12733873
TECHNIQUES FOR MIGRAINE DETECTION USING A WEARABLE DEVICE
2y 5m to grant Granted Sep 15, 2026
Patent 12727808
METHOD AND SYSTEM TO MANAGE ADAPTIVE SENSING
3y 11m to grant Granted Sep 08, 2026
Patent 12714858
MEDICAL DEVICE FOR CLOSED LOOP VAGAL NERVE STIMULATION
3y 1m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

8-9
Expected OA Rounds
85%
Grant Probability
89%
With Interview (+4.2%)
3y 1m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 778 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month